Biotechnology

Academician discusses healthcare advances over 70 years

BEIJING, Sept. 16, 2019 /PRNewswire/ -- A news report by China Daily discussing healthcare advances over 70 years inChina:   The life expectancy of Chinese people has risen from just 35 years to over 77 sincethe People's Republic of China was founded, owing to great efforts of ...

2019-09-16 19:37 1626

Atlas Antibodies Presents QPrEST Standards for Absolute Quantification of Proteins Using Mass Spectrometry

STOCKHOLM, Sept. 16, 2019 /PRNewswire/ -- Atlas Antibodies AB, a leading supplier of advanced research reagents, announced today the introduction of pre-quantified QPrEST™ Protein Standards for absolute quantification of proteins in biological samples such as cell lysate and plasma using liquid ...

2019-09-16 16:01 1894

AdAlta secures licensing deal for the i-body platform with global medical technology and diagnostics firm, GE Healthcare

Highlights * AdAlta secures commercial agreement for its i-body platform with global medical technology and diagnostics firm, GE Healthcare. * Under the licensing deal, the two companies will develop i-bodies for diagnostic imaging. * AdAlta will screen its novel i-body library on a number ...

2019-09-16 15:44 1799

ZEISS to showcase advancements in digital and surgical technology at ESCRS 2019

New digital and industry first solutions from ZEISS will be presented at the European Society of Cataract and Refractive Surgery (ESCRS) fromSeptember 14 - 18, 2019 PARIS, Sept. 14, 2019 /PRNewswire/ -- During the 2019 European Society of Cataract and Refractive Surgery (ESCRS) Annual Meeting in...

2019-09-14 13:00 2874

Kazia wins ANZLF Trans-Tasman Innovation & Growth Award and reports new data from clinical trial in childhood brain cancer

SYDNEY, Sept. 13, 2019 /PRNewswire/ -- Australian oncology-focused biotech company Kazia Therapeutics Ltd (ASX: KZA, NASDAQ: KZIA) is pleased to announce that it has been named as a winner in the 2019 ANZLF Trans-Tasman Innovation & Growth Awards. The Awards celebrate the innovation, growth and ...

2019-09-13 20:00 7397

CROMSOURCE Consolidates Its Hybrid Services Model

VERONA, Italy, Sept. 12, 2019 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO), has announced consolidation of its Hybrid Services Model.  Due to client demand, CROMSOURCE has further refined its Hybrid Services to be able to provide its pharmaceutical, medical de...

2019-09-12 22:18 3437

St Jude Study of GDC-0084 in DIPG Successfully Completes First Stage; Second Part of Study Now Underway

SYDNEY, Sept. 12, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that St Jude Children's Research Hospital has successfully completed the first stage of its ongoing phase I study of Kazia's in...

2019-09-12 21:10 7478

Menarini: Elcin Barker Ergun Group CEO

FLORENCE, Italy, Sept. 12, 2019 /PRNewswire/ -- The Board of Directors has appointed Mrs.Elcin Barker Ergun as CEO of Menarini Group. "Elcin Barker Ergun is the ideal addition to the Menarini team, in order to continue the agenda of growth in geography and therapeutic areas," commented Eric C...

2019-09-12 20:38 3954

Strekin AG Announces Completion of Patient Recruitment in the RESTORE Phase 3 Clinical Study of STR001

BASEL, Switzerland, Sept. 12, 2019 /PRNewswire/ -- Strekin AG (www.strekin.com ), a biopharmaceutical company focused on treatments for hearing loss, announced today that it has successfully completed patient recruitment in the RESTORE study, an international, randomized, ...

2019-09-12 14:15 2918

deCODE in Iceland Agrees to Sequence Half of UK Biobanks Participants

REYKJAVIK, Iceland, Sept. 12, 2019 /PRNewswire/ -- deCODE genetics in Iceland has entered into an agreement with a consortium of government, charity, researchers and world leading biopharmaceutical and healthcare companies to undertake whole genome sequencing of UK Biobank participants. The proje...

2019-09-12 00:25 2594

3SBio's MSCI ESG Rating Upgraded to BBB, Ranking at the Forefront of the Global Biotechnology Industry

SHANGHAI, Sept. 11, 2019 /PRNewswire/ -- According to Morgan Stanley Capital International's (MSCI) latest set of ESG ratings, 3SBio has been upgraded to BBB status, surpassing that of 61% of companies in the global biotechnology industry. MSCI ESG ratings focus on ESG issues that have a substan...

2019-09-11 16:52 2815

Clarivate Analytics acquires the SequenceBase business to expand its search and analysis capabilities for the life sciences IP market

Derwent, a Clarivate Analytics company and world-leading IP intelligence provider, to offer sequence searching for the fast-growing biologics market. LONDON and PHILADELPHIA, Sept. 9, 2019 /PRNewswire/ -- Clarivate Analytics plc (NYSE:CCC;CCC.WS), a global leader in providing trusted insights and...

2019-09-09 19:00 13741

EW Nutrition, Awarded the 2019 Outstanding Contribution Award for Reducing Antibiotic Resistance in the Layer Industry

- Picture is available at AP Images (http://www.apimages.com ) - GUANGZHOU, China, Sept. 9, 2019 /PRNewswire/ -- On August 28-29, the BBS & Excellent Product Award Ceremony for Reducing Antibiotic Resistance for the Layer Industry was held inGuangzhou. China's Ministr...

2019-09-09 18:28 2761

Newly Published ROSacea COnsensus (ROSCO) Expert Recommendations Encourage Dermatologists to Upweight Burden-related Discussions, Aim For 'Complete Clearance' of Symptoms and Consider Combination Therapy For Severe Patients

LAUSANNE, Switzerland, Sept. 9, 2019 /PRNewswire/ -- Published online in the British Journal of Dermatology , updated global recommendations from the ROSacea COnsensus (ROSCO) expert panel call on dermatologists to recognize the importance o...

2019-09-09 16:12 2901

Occlutech AFR Heart Failure Device Obtains CE Mark Approval

SCHAFFHAUSEN, Switzerland, Sept. 6, 2019 /PRNewswire/ -- Occlutech AG announced today that its atrial flow regulator, the Occlutech AFR device, has obtained CE mark approval clearing it for sales on the European CE regulated market. Occlutech AFR is a next generation intra-atrial shunt device, in...

2019-09-06 18:15 2704

Winners Of The 2020 Breakthrough Prize In Life Sciences, Fundamental Physics And Mathematics Announced

SAN FRANCISCO, Sept. 5, 2019 /PRNewswire/ -- The Breakthrough Prize Foundation and its founding sponsors –Sergey Brin, Priscilla Chan and Mark Zuckerberg, Ma Huateng,Yuri and Julia Milner, and Anne Wojcicki – today announced the recipients of the 2020 Breakthrough Prize and 2020 New Horizons Priz...

2019-09-05 23:00 3672

Berkeley Lights Opens Shanghai Location

- Nobel Laureate, Professor James E. Rothman, PhD, to speak at all-day symposium onSeptember 5th - China Rep Office located in one of China's leading high-tech industry clusters SHANGHAI and EMERYVILLE, California, Sept. 5, 2019 /PRNewswire/ -- Berkeley Lights, Inc. (BLI), a pioneer and leader ...

2019-09-05 08:06 2075

CROMSOURCE Continues US Growth With New Office in Research Triangle Park

CARY, North Carolina, Sept. 4, 2019 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO) has just opened a newly expanded office inCary, NC. Due to the growth of CROMSOURCE in the United States over the past few years, this new location serves as a complement to two ...

2019-09-04 21:00 1805

IDTechEx Research: The Future of Wearables is Medical

BOSTON, Sept. 4, 2019 /PRNewswire/ -- Wearable technology and medical devices have many prominent synergies. Electronic devices on the body are perfectly placed for sensors to collect data relevant to healthcare, with communication options allowing them to be the gateway to digital health data. C...

2019-09-04 10:00 4055

WuXi AppTec Launches DNA Encoded Library (DEL) Service Package "DELight" to Expedite Early Drug Discovery

SHANGHAI and BOSTON, Sept. 3, 2019 /PRNewswire/ -- WuXi AppTec today announced its launch of DELight, a novel DNA Encoded Library (DEL) service package, providing cost-effective and efficient hit finding services to expedite early drug discovery and bring new medicines to patients faster. DELigh...

2019-09-04 08:00 1845